Patterns of failure after immunotherapy with checkpoint inhibitors predict durable progression-free survival after local therapy for metastatic melanoma

BACKGROUND: Checkpoint inhibitors (CPI) have revolutionized the treatment of metastatic melanoma, but most patients treated with CPI eventually develop progressive disease. Local therapy including surgery, ablation or stereotactic body radiotherapy (SBRT) may be useful to manage limited progression,...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:J Immunother Cancer
Main Authors: Klemen, Nicholas D., Wang, Melinda, Feingold, Paul L., Cooper, Kirsten, Pavri, Sabrina N., Han, Dale, Detterbeck, Frank C., Boffa, Daniel J., Khan, Sajid A., Olino, Kelly, Clune, James, Ariyan, Stephan, Salem, Ronald R., Weiss, Sarah A., Kluger, Harriet M., Sznol, Mario, Cha, Charles
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2019
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6657062/
https://ncbi.nlm.nih.gov/pubmed/31340861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s40425-019-0672-3
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados